2010 PUBLICATIONS
-
Shram MJ, Sellers EM, Romach MK. Oral ketamine as a positive control in human
abuse potential studies. Drug Alcohol Depend. 2011 Apr 1;114(2-3):185-93. Epub
2010 Nov 24. PubMed PMID: 21109365. -
Schoedel KA, McMorn S, Chakraborty B, Zerbe K, Sellers EM. Reduced cognitive
and psychomotor impairment with extended-release oxymorphone versus
controlled-release oxycodone. Pain Physician. 2010 Nov-Dec;13(6):561-73. PubMed
PMID: 21102969.
-
Mansbach RS, Schoedel KA, Kittrelle JP, Sellers EM. The role of adverse events
and related safety data in the pre-market evaluation of drug abuse potential.
Drug Alcohol Depend. 2010 Dec 1;112(3):173-7. PubMed PMID: 20817417. -
Milovan D, Almeida L, Romach MK, Nunes T, Rocha JF, Sokowloska M, Sellers EM,
Soares-da-Silva P. Effect of eslicarbazepine acetate and oxcarbazepine on
cognition and psychomotor function in healthy volunteers. Epilepsy Behav. 2010
Aug;18(4):366-73. Epub 2010 Jun 18. PubMed PMID: 20708576.
-
Schoedel KA, Meier D, Chakraborty B, Manniche PM, Sellers EM. Subjective and
objective effects of the novel triple reuptake inhibitor tesofensine in
recreational stimulant users. Clin Pharmacol Ther. 2010 Jul;88(1):69-78. Epub
2010 Jun 2. PubMed PMID: 20520602.
-
Mwenifumbo JC, Zhou Q, Benowitz NL, Sellers EM, Tyndale RF. New CYP2A6 gene
deletion and conversion variants in a population of Black African descent.
Pharmacogenomics. 2010 Feb;11(2):189-98. PubMed PMID: 20136358; PubMed Central
PMCID: PMC2922202. -
Shram MJ, Sathyan G, Khanna S, Tudor IC, Nath R, Thipphawong J, Sellers EM.
Evaluation of the abuse potential of extended release hydromorphone versus
immediate release hydromorphone. J Clin Psychopharmacol. 2010 Feb;30(1):25-33.
PubMed PMID: 20075644. -
Zawertailo LA, Tyndale RF, Busto U, Sellers EM. Effect of metabolic blockade
on the psychoactive effects of dextromethorphan. Hum Psychopharmacol. 2010
Jan;25(1):71-9. PubMed PMID: 20041473.